Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited

NNASDAQ:ZYBT
1.43
USD
-0.07
(-4.67%)
54.50MMarket Cap

Total Valuation

USD

As of December 31, 2025, Zhengye Biotechnology Holding Limited carries a market capitalization of 54.50M, placing it among publicly traded companies globally. Its enterprise value stands at 65.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap54.50M
Enterprise Value65.95M

Share Statistics

As of December 31, 2025, Zhengye Biotechnology Holding Limited has 47.39M shares outstanding.

Shares Outstanding47.39M

Valuation Ratios

These figures are as of December 31, 2025.

PB Ratio1.53
P/TBV Ratio1.95

Financial Position

As of December 31, 2025, Zhengye Biotechnology Holding Limited maintains a current ratio of 1.14, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

Current Ratio1.14
Quick Ratio0.58
Debt / Equity24.48

Financial Efficiency

These figures cover the twelve months ended December 31, 2025.

Employee Count273.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Zhengye Biotechnology Holding Limited's stock has declined approximately 35.01% over the past 52 weeks. The 50-day moving average sits at 1.41, while the 200-day moving average is 1.18.

52-Week Price Change-35.01%
50-Day Moving Average1.41
200-Day Moving Average1.18

Balance Sheet

USD

As of December 31, 2025, Zhengye Biotechnology Holding Limited holds 7.42M in cash and equivalents against 10.74M in total debt, resulting in a net debt position of 3.48M. Total book value stands at 35.73M, with working capital of 2.42M providing operational flexibility.

Cash & Cash Equivalents7.42M
Total Debt10.74M
Net Debt3.48M
Equity (Book Value)35.73M
Book Value Per Share0.75
Working Capital2.42M